Microfluidics for Healthcare Application Market to grow by USD 110.2 Billion from 2024-2028, driven by compact microfluidic devices and AI-powered evolution

Microfluidics for Healthcare Application Market to grow by USD 110.2 Billion from 2024-2028, driven by compact microfluidic devices and AI-powered evolution

NEW YORK, Nov. 27, 2024 /PRNewswire/ — Report on how AI is driving market transformation – The global microfluidics for healthcare application market size is estimated to grow by USD 110.2 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  27.16%  during the forecast period. Compact size of microfluidic devices is driving market growth, with a trend towards use of paper-based microfluidic device . However, changes in properties of fluids at microscopic level  poses a challenge.Key market players include 908 Devices Inc., Agilent Technologies Inc., BioMerieux SA, Bio Rad Laboratories Inc., Blacktrace Holdings Ltd., Cellix Ltd., Danaher Corp., Elveflow, Fluigent SA, General Electric Co., Hamilton Co., Illumina Inc., Microfluidic Chipshop GmbH, MICRUX FLUIDIC S.L., Perkin Elmer Inc., QIAGEN NV, SMC Corp., Teledyne Technologies Inc., Thermo Fisher Scientific Inc., and uFluidix Inc..

Technavio has announced its latest market research report titled Global microfluidics market for healthcare application 2024-2028
Technavio has announced its latest market research report titled Global microfluidics market for healthcare application 2024-2028

Key insights into market evolution with AI-powered analysis. Explore trends, segmentation, and growth drivers- View Free Sample PDF

Microfluidics For Healthcare Application Market Scope

Report Coverage

Details

Base year

2023

Historic period

2018 – 2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 27.16%

Market growth 2024-2028

USD 110.2 billion

Market structure

Fragmented

YoY growth 2022-2023 (%)

20.89

Regional analysis

North America, Europe, APAC, South America, and Middle East and Africa

Performing market contribution

North America at 40%

Key countries

US, China, Germany, UK, and Japan

Key companies profiled

908 Devices Inc., Agilent Technologies Inc., BioMerieux SA, Bio Rad Laboratories Inc., Blacktrace Holdings Ltd., Cellix Ltd., Danaher Corp., Elveflow, Fluigent SA, General Electric Co., Hamilton Co., Illumina Inc., Microfluidic Chipshop GmbH, MICRUX FLUIDIC S.L., Perkin Elmer Inc., QIAGEN NV, SMC Corp., Teledyne Technologies Inc., Thermo Fisher Scientific Inc., and uFluidix Inc.

Market Driver

The microfluidics market is experiencing significant growth in various healthcare applications, particularly in life sciences and medical research. Soft lithography is a key technology driving this trend, enabling the production of microfluidic devices for drug discovery, insulin pumps, intelligent medications, and subcutaneous patches. Commercialization of these technologies is on the rise, with applications in the environment industry, molecular biology, PoC diagnostics, and PCR systems. Hospitals and diagnostic centers are increasingly adopting microfluidics for proteomics, genomics technologies, viral load testing, and infection detection. Microfluidic devices are revolutionizing healthcare with fast gene systems, nanopore technologies, immunoassays, opto readers, organs on chip, and cluster well chips. Glass, silicon, and polymers are common materials used in microfluidic chips for high precision PCR, micro dispensing, clinical diagnostics, and drug delivery systems. Capillary electrophoresis and microneedles are also gaining popularity in this field. Overall, microfluidics is transforming healthcare through its applications in biotechnology, pharmaceutical, and clinical diagnostics.

link

Leave a Reply

Your email address will not be published. Required fields are marked *